Merck drug Keytruda succeeds in late-stage esophageal cancer trial
Merck & Co’s blockbuster drug Keytruda met the main goal of a late-stage trial testing… Read More
7 years ago
Merck & Co’s blockbuster drug Keytruda met the main goal of a late-stage trial testing… Read More